Moore Capital Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-70,000
Closed -$725K 328
2018
Q4
$725K Hold
70,000
0.03% 181
2018
Q3
$1.2M Sell
70,000
-157,000
-69% -$2.7M 0.03% 217
2018
Q2
$4.09M Buy
227,000
+172,000
+313% +$3.45M 0.1% 144
2018
Q1
$963K Buy
+55,000
New +$1.15M 0.02% 196
2015
Q2
Sell
-30,000
Closed -$563K 498
2015
Q1
$563K Buy
+30,000
New +$514K 0.01% 382
2014
Q4
Sell
-50,000
Closed -$1.63M 393
2014
Q3
$1.63M Sell
50,000
-100,000
-67% -$3.4M 0.04% 296
2014
Q2
$5.24M Buy
150,000
+50,000
+50% +$1.64M 0.13% 177
2014
Q1
$3.17M Buy
+100,000
New +$2.78M 0.06% 232

Other funds holding PTEN

Moore Capital Management's PTEN Position: Q1 2019 in Review

Moore Capital Management sold out of Patterson-UTI (PTEN) in Q1 2019, closing a stake of 70,000 shares — an estimated $725K sold.

Moore Capital Management first reported a position in PTEN in Q1 2014 and held it in 8 quarters. The position peaked at $5.24M in Q2 2014. 303 funds tracked by Wall St. Rank hold PTEN as of Q1 2019.

  • Moore Capital Management reported no remaining Patterson-UTI position as of Q1 2019 after selling out during the quarter.
  • Moore Capital Management sold 70,000 Patterson-UTI shares in Q1 2019, an estimated $725K.
  • Moore Capital Management first reported a position in Patterson-UTI in Q1 2014 and held it in 8 quarters.
  • Moore Capital Management's Patterson-UTI position peaked at $5.24M in Q2 2014.
  • 303 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2019.

Based on Moore Capital Management's 13F filing for Q1 2019, filed 15 May 2019.